Early plasma therapy may help prevent severe COVID-19 in patients over age 65: study
TORONTO -- A new study has found that administering convalescent plasma with a high concentration of antibodies against COVID-19 early on in mildly ill older adults may help reduced the progression of the disease. The study, conducted by Argentina-based non-profit Fundación Infant, found that convalescent plasma therapy could "significantly reduce" the need for oxygen support among COVID-19 patients over 65 years old if administered within 72 hours after the onset of symptoms. Lead investigator of the study, Dr. Fernando Polack, said in a press release the findings suggest a new appro...
Source: ctvnews.ca